Your browser doesn't support javascript.
loading
Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the Future.
Wuchner, Klaus; Yi, Linda; Chery, Cyrille; Nikels, Felix; Junge, Friederike; Crotts, George; Rinaldi, Gianluca; Starkey, Jason A; Bechtold-Peters, Karoline; Shuman, Melissa; Leiss, Michael; Jahn, Michael; Garidel, Patrick; de Ruiter, Rien; Richer, Sarah M; Cao, Shawn; Peuker, Sebastian; Huille, Sylvain; Wang, Tingting; Brun, Virginie Le.
Afiliación
  • Wuchner K; Janssen R&D, DPDS BTDS Analytical Development, Hochstr. 201, 8200 Schaffhausen, Switzerland. Electronic address: kwuchne1@its.jnj.com.
  • Yi L; Analytical Development, Biogen, Morrisville, NC 27709, USA.
  • Chery C; UCB, Analytical Development Sciences for Biologicals, Chemin du Foriest, 1420 Braine-l'Alleud, Belgium.
  • Nikels F; Boehringer Ingelheim Pharma GmbH & Co KG, Innovation Unit, Birkendorfer Str. 65, 88397 Biberach an der Riss, Germany.
  • Junge F; Analytical Research and Development, NBE Analytical R&D, AbbVie Deutschland GmbH& Co. KG, Knollstraße, 67061 Ludwigshafen, Germany.
  • Crotts G; GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, USA.
  • Rinaldi G; Merck Serono SpA, Guidonia Montecelio, Italy, an affiliate of Merck KGaA, Darmstadt, Germany.
  • Starkey JA; Pfizer, Inc. Biotherapeutics Pharmaceutical Sciences, Analytical Research and Development 875 W. Chesterfield Parkway, Chesterfield, MO 63017, USA.
  • Bechtold-Peters K; Novartis Pharma AG, TRD Biologics & CGT, GDD, 4002 Basel, Switzerland.
  • Shuman M; GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, USA.
  • Leiss M; Pharma Technical Development Analytics, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany.
  • Jahn M; Lonza AG, Drug Product Services, Hochbergerstr. 60G, CH-4057 Basel, Switzerland.
  • Garidel P; Boehringer Ingelheim Pharma GmbH & Co KG, Innovation Unit, Birkendorfer Str. 65, 88397 Biberach an der Riss, Germany.
  • de Ruiter R; Byondis B.V., Downstream Processing, Nijmegen, the Netherlands.
  • Richer SM; Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Cao S; Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, USA.
  • Peuker S; Bayer AG, Product Supply, Analytical Development and Clinical QC for Biotech Products, Friedrich-Ebert-Str. 217-233, 42117 Wuppertal, Germany.
  • Huille S; Sanofi R&D, Biologics Drug Products Development,13 quai Jules Guesde, 94403 Vitry-sur Seine, France.
  • Wang T; Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Brun VL; Lonza AG, Drug Product Services, Hochbergerstr. 60G, CH-4057 Basel, Switzerland.
J Pharm Sci ; 111(11): 2955-2967, 2022 11.
Article en En | MEDLINE | ID: mdl-36002077
ABSTRACT
Polysorbate (PS) 20 and 80 are the main surfactants used to stabilize biopharmaceutical products. Industry practices on various aspects of PS based on a confidential survey and following discussions by 16 globally acting major biotechnology companies is presented in two publications. Part 1 summarizes the current practice and use of PS during manufacture in addition to aspects like current understanding of the (in)stability of PS, the routine QC testing and control of PS, and selected regulatory aspects of PS.1 The current part 2 of the survey focusses on understanding, monitoring, prediction, and mitigation of PS degradation pathways in order to propose an effective control strategy. The results of the survey and extensive cross-company discussions are put into relation with currently available scientific literature.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Polisorbatos / Productos Biológicos Idioma: En Revista: J Pharm Sci Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Polisorbatos / Productos Biológicos Idioma: En Revista: J Pharm Sci Año: 2022 Tipo del documento: Article